N-(4-chlorobenzyl)-2-(1-cyclohexen-1-yl)ethanamine hydrochloride, 95.0%, 1g

Ethyl beta-Iodopropionate, 96.0%, 250mg

(1S)-8-azaspiro[bicyclo[3.2.1]octane-3,4'-imidazolidine]-2',5'-dione hydrochloride, 95%, 25mg

6-Bromo-2-methylnicotinonitrile, 95.0%, 100mg

4-(2-METHOXYPHENOXY)BENZYLAMINE HCL, 95.0%, 1g

tert-butyl (3-hydroxybutyl)carbamate, 98.0%, 100mg

2-([1,1'-Biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

2-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)ethan-1-amine, 95%, 1g

(S)-1-((1S,3aR,4S,7aR)-4-((tert-Butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)ethan-1-ol, 98%, 50mg

Reaction vial rack SEKUROKA® for anti-radiation box Maxi, Gesch. for, 5 ml scintillation vials, 1 piece

1-Bromo-2,5-dimethoxy-4-((4-methoxybenzyl)oxy)benzene, 95.0%, 250mg

(S)-7-AMINO-5-BENZYL-5-AZASPIRO[2.4]-HEPTANE 2HCL, 95.0%, 250mg

rel-4,4,5,5-Tetramethyl-2-[(1R,2S)-2-methylcyclopropyl]-1,3,2-dioxaborolane, 98%, 250mg